Literature DB >> 3609013

Structure and regulation of eukaryotic initiation factor eIF-2. Sequence of the site in the alpha subunit phosphorylated by the haem-controlled repressor and by the double-stranded RNA-activated inhibitor.

D R Colthurst, D G Campbell, C G Proud.   

Abstract

Eukaryotic protein synthesis initiation factor 2 (eIF-2) can be phosphorylated on its alpha subunit by two well-characterised protein kinases, termed the haem-controlled repressor (HCR) and the double-stranded RNA-activated inhibitor (dsI). Phosphorylation of eIF-2 by these kinases is thought to be important in the regulation of peptide-chain initiation. We report the location of the serine residue in the alpha subunit, which is phosphorylated by both these enzymes. Limited tryptic digestion and subsequent cyanogen bromide treatment of rat liver eIF-2 phosphorylated by HCR yielded one major phosphopeptide. This peptide had the sequence Ile-Leu-Leu-Ser-Glu-Leu-Ser(P)-Arg-Arg. The same major phosphopeptide was obtained from rabbit reticulocyte eIF-2 phosphorylated by HCR or dsI as judged by its behaviour on two-dimensional mapping and reverse-phase chromatography. In all cases the phosphorylated residue was found to be serine-7, and not serine-4, of the above sequence as determined from sequence analysis and by subdigestion of the peptide with Staphylococcus aureus V8 proteinase.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3609013     DOI: 10.1111/j.1432-1033.1987.tb13523.x

Source DB:  PubMed          Journal:  Eur J Biochem        ISSN: 0014-2956


  35 in total

1.  The C-terminal, third conserved motif of the protein activator PACT plays an essential role in the activation of double-stranded-RNA-dependent protein kinase (PKR).

Authors:  Xu Huang; Brian Hutchins; Rekha C Patel
Journal:  Biochem J       Date:  2002-08-15       Impact factor: 3.857

2.  Mutations activating the yeast eIF-2 alpha kinase GCN2: isolation of alleles altering the domain related to histidyl-tRNA synthetases.

Authors:  M Ramirez; R C Wek; C R Vazquez de Aldana; B M Jackson; B Freeman; A G Hinnebusch
Journal:  Mol Cell Biol       Date:  1992-12       Impact factor: 4.272

3.  Generation and comprehensive analysis of an influenza virus polymerase cellular interaction network.

Authors:  Lionel Tafforeau; Thibault Chantier; Fabrine Pradezynski; Johann Pellet; Philippe E Mangeot; Pierre-Olivier Vidalain; Patrice Andre; Chantal Rabourdin-Combe; Vincent Lotteau
Journal:  J Virol       Date:  2011-10-12       Impact factor: 5.103

4.  The phosphorylation state of eucaryotic initiation factor 2 alters translational efficiency of specific mRNAs.

Authors:  R J Kaufman; M V Davies; V K Pathak; J W Hershey
Journal:  Mol Cell Biol       Date:  1989-03       Impact factor: 4.272

Review 5.  Regulation of protein synthesis by the heme-regulated eIF2alpha kinase: relevance to anemias.

Authors:  Jane-Jane Chen
Journal:  Blood       Date:  2007-04-01       Impact factor: 22.113

6.  Identification of the heparin-binding domains of the interferon-induced protein kinase, PKR.

Authors:  Stephen Fasciano; Brian Hutchins; Indhira Handy; Rekha C Patel
Journal:  FEBS J       Date:  2005-03       Impact factor: 5.542

Review 7.  Mechanism and regulation of eukaryotic protein synthesis.

Authors:  W C Merrick
Journal:  Microbiol Rev       Date:  1992-06

Review 8.  Adenovirus virus-associated RNA and translation control.

Authors:  M B Mathews; T Shenk
Journal:  J Virol       Date:  1991-11       Impact factor: 5.103

9.  The La antigen inhibits the activation of the interferon-inducible protein kinase PKR by sequestering and unwinding double-stranded RNA.

Authors:  Q Xiao; T V Sharp; I W Jeffrey; M C James; G J Pruijn; W J van Venrooij; M J Clemens
Journal:  Nucleic Acids Res       Date:  1994-07-11       Impact factor: 16.971

10.  The interferon-inducible double-stranded RNA-activated protein kinase self-associates in vitro and in vivo.

Authors:  R C Patel; P Stanton; N M McMillan; B R Williams; G C Sen
Journal:  Proc Natl Acad Sci U S A       Date:  1995-08-29       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.